Demographic and clinical characteristics of patients with LVAD
| Characteristic . | N = 12 . |
|---|---|
| Age, y | 65.6 ± 11.6 |
| Female sex, N (%) | 5 (41.7) |
| LVAD as destination therapy, N (%) | 10 (83.3) |
| Laboratory findings | |
| Hemoglobin, g/dL | 11.1 ± 2.5 |
| Platelet count, × 103/μL | 238.2 ± 106.9 |
| INR | 2.1 ± 0.7 |
| Creatinine, mg/dL | 1.3 ± 0.1 |
| LDH, U/L | 319.6 ± 40.7 |
| LVAD parameters | |
| RPM | 8631 ± 792 |
| PI | 5.11 ± 1.3 |
| PP, watts | 5.8 ± 1.21 |
| Characteristic . | N = 12 . |
|---|---|
| Age, y | 65.6 ± 11.6 |
| Female sex, N (%) | 5 (41.7) |
| LVAD as destination therapy, N (%) | 10 (83.3) |
| Laboratory findings | |
| Hemoglobin, g/dL | 11.1 ± 2.5 |
| Platelet count, × 103/μL | 238.2 ± 106.9 |
| INR | 2.1 ± 0.7 |
| Creatinine, mg/dL | 1.3 ± 0.1 |
| LDH, U/L | 319.6 ± 40.7 |
| LVAD parameters | |
| RPM | 8631 ± 792 |
| PI | 5.11 ± 1.3 |
| PP, watts | 5.8 ± 1.21 |
Continuous values are expressed as mean ± standard deviation.
INR, International Normalized Ratio; LDH, lactate dehydrogenase; PI, pulsatility index; PP, pump power; RPM, revolutions per minute.